Oliver Lagore Vanvalin Investment Group Moderna, Inc. Transaction History
Oliver Lagore Vanvalin Investment Group
- $370 Million
- Q4 2024
A detailed history of Oliver Lagore Vanvalin Investment Group transactions in Moderna, Inc. stock. As of the latest transaction made, Oliver Lagore Vanvalin Investment Group holds 260 shares of MRNA stock, worth $7,238. This represents 0.0% of its overall portfolio holdings.
Number of Shares
260
Previous 764
65.97%
Holding current value
$7,238
Previous $51,000
80.39%
% of portfolio
0.0%
Previous 0.01%
Shares
7 transactions
Others Institutions Holding MRNA
# of Institutions
910Shares Held
252MCall Options Held
19MPut Options Held
24.3M-
Vanguard Group Inc Valley Forge, PA40.3MShares$1.12 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$712 Million0.07% of portfolio
-
Baillie Gifford & CO24.9MShares$695 Million0.64% of portfolio
-
State Street Corp Boston, MA17.6MShares$489 Million0.03% of portfolio
-
Theleme Partners LLP London, X07.31MShares$203 Million20.37% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $10.9B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...